Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

3.25
0.0000
Post-market: 3.19-0.0600-1.85%19:32 EDT
Volume:2.27M
Turnover:7.37M
Market Cap:322.82M
PE:-5.52
High:3.30
Open:3.25
Low:3.17
Close:3.25
Loading ...

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire
·
01 Apr

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) P/S Is On The Mark

Simply Wall St.
·
22 Mar

Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Mar

Raymond James Keeps Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Alliance Global Partners Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Aquestive Therapeutics Inc : Raymond James Cuts Target Price to $7 From $8

THOMSON REUTERS
·
07 Mar

Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
07 Mar

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
06 Mar

Aquestive Therapeutics Q4 Net Loss Widens, Revenue Falls; 2025 Revenue Outlook Issued

MT Newswires Live
·
06 Mar

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics

Zacks
·
06 Mar

Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

BRIEF-Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Reuters
·
06 Mar

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
06 Mar

Aquestive Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
06 Mar

Aquestive Therapeutics Inc: Qtrly Shr Loss $0.19

THOMSON REUTERS
·
06 Mar

Aquestive Therapeutics Inc Outlook FY Total Revenue $47Mln to $56 Mln

THOMSON REUTERS
·
06 Mar

Aquestive Therapeutics, Inc. Q4 Adjusted Ebitda USD -11.029 Million

THOMSON REUTERS
·
06 Mar

Aquestive Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
04 Mar

Aquestive Therapeutics to Participate in Two Upcoming Conferences in March

GlobeNewswire
·
26 Feb